MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617085784 A) filed by Pharmamax Pharmaceuticals, Ltd. on July 13, 2026, for Compound And Salt Thereof, Use In Preparation Of Drug For Treating Cancer And Kinase Inhibitor, And Drug For Treating Cancer.
Inventors include Fan, Fangtian; He, Qiwei; Tao, Yu; and Dai, Wenting.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: The present invention belongs to the technical field of drug synthesis, and particularly relates to a compound and a salt thereof, the use in the preparation of a drug for treating cancer and a kinase inhibitor, and a drug for treating cancer. Provided in the present invention are a CHMFL-FLT3-122 compound deuterated at a specific position and a pharmaceutically acceptable salt thereof. Provided is the use of the compound or the pharmaceutically acceptable salt thereof in the preparation of a drug for treating cancer and a kinase inhibitor. Also provided is a drug for treating cancer. The compound and the pharmaceutically acceptable salt thereof provided by the present invention have a strong anti-cancer activity, good metabolic stability and pharmacokinetic properties, and have excellent application prospects.
Disclaimer: Curated by HT Syndication.
